Umecrine Cognition

Solna, Sweden · Founded 2006 · Privately Held (backing)

Developer of pharmaceutical drugs designed to treat cognitive neurological disorders. Umecrine Cognition is based in Solna, Sweden and was founded in 2006. Its last reported valuation was $71.5 million in Jul 2021. It has raised $28.1 million.

Last reported valuation
$71.5M
Oct 2026
Priced at
—
Total raised
$28.1M
Last round
—

Who backs Umecrine Cognition?

9 investors
InvestorType
Almi InvestVenture capital
NorrlandsfondenOther
AB Ility—
Fort Knox—
KDventures—
Karolinska Development—
Partnerinvest Norr—
Ribbskottet—
Umeå Biotech Incubator—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Umecrine Cognition investors

9 investors are on record for Umecrine Cognition, including Almi Invest, Norrlandsfonden, AB Ility and Fort Knox.

Free account
More of Umecrine Cognition with a free account
  • ·Watch Umecrine Cognition: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Umecrine Cognition. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View